Simone Esposito

10PUBLICATIONS
43CO-AUTHORS
Molecular targetsPharmacogenomicsIntangible heritageBiologically active moleculesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 13, 2026
Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers.

|Feb 17, 2026
A Pragmatic PBPK-Driven Strategy to Guide ADME Characterization and Early Human PK Prediction for ECCS Class 1B/3B Compounds.

David Cebrián, Line Oste, Dries Van den Bossche

|Jul 07, 2025
Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates.

Longbin Liu, Peter D Johnson, Matthew R Mills

|Jan 31, 2025
Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases.

Sergio Mallart, Raffaele Ingenito, Paola Magotti

|Aug 30, 2022
Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations.

Simone Esposito, Laura Orsatti, Vincenzo Pucci

|Aug 05, 2021
[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins.

Longbin Liu, Peter D Johnson, Michael E Prime

Pageof 2

Frequent Collaborators

5 joint publications

Laura Orsatti

3 joint publications

Peter D Johnson

3 joint publications

Longbin Liu

3 joint publications

Jonathan A Bard